Methamphetamine, Innate Immunity and HIV
甲基苯丙胺、先天免疫和艾滋病毒
基本信息
- 批准号:9308910
- 负责人:
- 金额:$ 35.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAstrocytesBiological AssayBrain-Derived Neurotrophic FactorCCL2 geneCD4 Lymphocyte CountCD4 Positive T LymphocytesCell CountCellsChronicClinicalCytoprotectionDevelopmentDiseaseHIVHIV InfectionsHLA-DR AntigensHealthImmuneImmune responseImmunityImmunologic MarkersImpairmentIn VitroIndividualInfection ControlInflammatoryInterferon-alphaInterferonsInterleukin-1Interleukin-10Interleukin-6LigandsMeasuresMediatingMethamphetamineMicroRNAsMicrogliaMonitorNTF3 geneNatural ImmunityNeurogliaNeuronal InjuryNeuronsOutcomePeripheral Blood Mononuclear CellPersonsPlasmaPredispositionProductionResearchSignal PathwaySignal TransductionSpecimenStudy SubjectSystemT-LymphocyteTLR3 geneTNF geneUnited StatesVirus Diseasesbasechemokinecirculating microRNAclinically relevantclinically significantcytokinedrug of abuseexosomeimmune activationin vivomacrophagemethamphetamine actionmethamphetamine effectmethamphetamine usemethamphetamine usermonocyteneurotoxicityneurotropicnovelpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): Methamphetamine (METH) is one of the most commonly abused drugs among HIV-infected individuals in the United States. METH use is associated with the worst health outcomes in HIV-infected individuals, as METH adversely impacts immunological responses to viral infections. Although METH has been indicated as a facilitating factor in the development of HIV disease, the mechanism(s) of METH actions on HIV remains to be determined. Our in vitro studies showed that METH could enhance HIV replication and impair intracellular innate immunity. Thus, we proposed further studies using the clinical specimens from the unique and well-characterized study subjects, investigating the in vivo and ex vivo impact of METH on RIG- I/TLR3 signaling-mediated anti-HIV activities. We hypothesize that METH suppresses intracellular innate immunity in primary immune cells (CD4+T cells, monocytes) and CNS cells (astrocytes, microglia), facilitating HIV infection and neuronal injury. We propose three specific aims to address this hypothesis: In aim 1, we will determine the plasma levels of exosome- derived HIV restriction miRNAs and immune activation markers in METH users with or without chronic HIV infection. In aim 2, we will determine the ex vivo and in vitro effects of METH on RIG-I/TLR3 signaling-mediated innate immunity against HIV. We will also examine the mechanisms involved in the actions of METH on RIG-I/TLR3 signaling and HIV infection. In aim 3, we will determine the effect of astroglial RIG-I/TLR3 signaling on HIV replication in microglia (glia-glia interaction) as well as the impact of METH on astroglial RIG-I/TLR3 signaling-mediated anti-HIV effect and neuronal cell protection. These proposed novel studies with combinational in vivo, ex vivo and in vitro approaches are clinically significant and relevant, as they will reveal previously unidentified mechanisms for the METH actions on HIV and the CNS. In addition, the proposed studies will identify the novel immunological markers for monitoring the impact of METH use on the development of HIV disease.
描述(申请人提供):甲基苯丙胺(冰毒)是美国艾滋病毒感染者中最常见的滥用药物之一。在艾滋病毒感染者中,冰毒的使用与最糟糕的健康后果有关,因为冰毒对病毒感染的免疫反应产生了不利影响。虽然冰毒已被认为是艾滋病毒疾病发展的促进因素,但冰毒对艾滋病毒的作用机制(S)仍有待确定。我们的体外研究表明,冰毒可以促进HIV的复制,并损害细胞内的天然免疫。因此,我们建议使用独特和具有良好特征的研究对象的临床标本进行进一步的研究,研究冰毒在体内和体外对RIG-I/TLR3信号介导的抗HIV活性的影响。我们推测,冰毒抑制了初级免疫细胞(CD4+T细胞、单核细胞)和中枢神经系统细胞(星形胶质细胞、小胶质细胞)的细胞内天然免疫,促进了HIV感染和神经元损伤。我们提出了三个具体的目标来解决这一假设:在目标1中,我们将测定有或没有慢性HIV感染的冰毒使用者血浆中外切体衍生的HIV限制性miRNAs和免疫激活标记物的水平。在目标2中,我们将确定冰毒在体外和体外对RIG-I/TLR3信号介导的抗HIV天然免疫的影响。我们还将研究METH对RIG-I/TLR3信号转导和HIV感染的作用机制。在目标3中,我们将确定星形胶质细胞RIG-I/TLR3信号对小胶质细胞中HIV复制的影响(胶质细胞-胶质细胞相互作用)以及METH对星形胶质细胞RIG-I/TLR3信号介导的抗HIV效应和神经细胞保护的影响。这些提出的结合体内、体外和体外方法的新研究具有临床意义和相关性,因为它们将揭示以前未知的冰毒对艾滋病毒和中枢神经系统的作用机制。此外,拟议的研究将确定新的免疫标记物,用于监测冰毒使用对艾滋病毒疾病发展的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WENZHE HO其他文献
WENZHE HO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WENZHE HO', 18)}}的其他基金
Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia
HIV原病毒的靶宿主表观遗传调控可增强小胶质细胞中病毒的深潜伏期
- 批准号:
10748760 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
- 批准号:
10210377 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10611364 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
- 批准号:
10031319 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10205018 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10398189 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10055449 - 财政年份:2020
- 资助金额:
$ 35.1万 - 项目类别:
Role of miRNAs in Methamphetamine/HIV-mediated Immune Activation
miRNA 在甲基苯丙胺/HIV 介导的免疫激活中的作用
- 批准号:
10357940 - 财政年份:2018
- 资助金额:
$ 35.1万 - 项目类别:
Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
- 批准号:
9381158 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
- 批准号:
9485926 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
相似国自然基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
- 批准号:31760279
- 批准年份:2017
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
相似海外基金
The contribution of astrocytes in behavioral flexibility
星形胶质细胞对行为灵活性的贡献
- 批准号:
24K18245 - 财政年份:2024
- 资助金额:
$ 35.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
阐明人星形胶质细胞中 APOE4 诱导的内溶酶体运输失调
- 批准号:
10670573 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
DNA methylation signatures of Alzheimer's disease in aged astrocytes
老年星形胶质细胞中阿尔茨海默病的 DNA 甲基化特征
- 批准号:
10807864 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Genetically-Encoded, Non-Invasive and Wireless Modulation of Calcium Dynamics in Astrocytes With Spatiotemporal Precision and Depth
具有时空精度和深度的星形胶质细胞钙动态的基因编码、非侵入性无线调节
- 批准号:
10562265 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Accelerating Functional Maturation of Human iPSC-Derived Astrocytes
加速人 iPSC 衍生的星形胶质细胞的功能成熟
- 批准号:
10699505 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Defining cell type-specific functions for the selective autophagy receptor p62 in neurons and astrocytes
定义神经元和星形胶质细胞中选择性自噬受体 p62 的细胞类型特异性功能
- 批准号:
10676686 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Astrocytes control the termination of oligodendrocyte precursor cell perivascular migration during CNS development
星形胶质细胞控制中枢神经系统发育过程中少突胶质细胞前体细胞血管周围迁移的终止
- 批准号:
10727537 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Multispectral Imaging of Neurons and Astrocytes: Revealing Spatiotemporal Organelle Phenotypes in Health and Neurodegeneration
神经元和星形胶质细胞的多光谱成像:揭示健康和神经退行性疾病中的时空细胞器表型
- 批准号:
10674346 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
The role of lateral orbitofrontal cortex astrocytes in alcohol drinking
外侧眶额皮质星形胶质细胞在饮酒中的作用
- 批准号:
10823447 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Investigating the role of diazepam binding inhibitor (DBI) in astrocytes and neural circuit maturation
研究地西泮结合抑制剂 (DBI) 在星形胶质细胞和神经回路成熟中的作用
- 批准号:
10567723 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:














{{item.name}}会员




